Universal Precautions in Pain Management A Rational Approach to Management of Chronic Pain

Similar documents
Fire the Molecule, Not the Patient! From Irresponsible Prescribing to Universal Precautions. Douglas Gourlay, MD, MSc, FRCPC, FASAM

Universal Precautions in Pain Medicine: A Rational Approach to the Treatment of Chronic Pain

KANSAS Kansas State Board of Healing Arts. Source: Kansas State Board of Healing Arts. Approved: October 17, 1998

Colorado State Board of Medical Examiners Policy

Universal Precautions and Opioid Risk. Assessment. Questions: How often do you screen your patients for risk of misuse when prescribing opioids?

Trainwreck: Addressing Complex Pharmacotherapy With the Inherited Pain Patient

Medication Agreements Promoting awareness, dialogue and level-set expectations

ASPMN Conference Baltimore, Maryland

The Impact of the Opioid Crisis. Deborah A. McMahan, MD Health Commissioner Allen County Department of Health

Measure #408: Opioid Therapy Follow-up Evaluation National Quality Strategy Domain: Effective Clinical Care

Recommendations in Opioid Prescribing Guidelines for Chronic Pain

Patient Agreement for the use of Opioid Medications

Within the Scope of Practice/Role of _X APRN RN LPN CNA ADVISORY OPINION PAIN MANAGEMENT GUIDELIINES

Community Opioid Load: Concept to Action in Kingston-KFLA

Liability, Informed Consent, and Risk Management 15 Thoughts for Pain Management Physicians

Missouri Guidelines for the Use of Controlled Substances for the Treatment of Pain

House of Pain? A Standardized Approach to Chronic Pain In the Patient-Centered Medical Home. MAJ Meghan Raleigh, MD 17 MAR 2014

Opioids, Helpful or Harmful? just as good as opioids and without the risk factor of overdosing. Many doctors are afraid of

Alberta WCB Policies & Information

Principles and language suggestions for talking with patients

Quality ID #414: Evaluation or Interview for Risk of Opioid Misuse National Quality Strategy Domain: Effective Clinical Care

Opioids: Use and Misuse/Steven Feinberg, MD; Scott Levy, MD, MPH, FACOEM

WILLIAMS, WYCKOFF & OSTRANDER, PLLC Attorneys at Law

Behavioral Health in PACE: Substance Abuse

5 A s Opioid therapy monitoring tool

Virginia. Prescribing and Dispensing Profile. Research current through November 2015.

Screener and Opioid Assessment for Patients with Pain- Revised (SOAPP -R)

Oklahoma. Prescribing and Dispensing Profile. Research current through November 2015.

Opioids drive continued increase in drug overdose deaths

Drugs & Alcohol. Lesson. By Carone Fitness. Drugs & Alcohol

Applying Universal Precautions to Chronic Opioid Therapy 5P s Assessment

California. Prescribing and Dispensing Profile. Research current through November 2015.

Tennessee. Prescribing and Dispensing Profile. Research current through November 2015.

Revised Appendix E of the Code of Professional Conduct promulgated in Issue No. 24 of the newsletter of the Medical Council in December 2017

OPIOIDS AND NON-CANCER PAIN

Vermont. Prescribing and Dispensing Profile. Research current through November 2015.

Substance use and addictive disorders in Palliative care

Rule Governing the Prescribing of Opioids for Pain

HOPE Agenda. Heroin, Opioid Prevention & Education WISCONSIN STATE REPRESENTATIVE JOHN NYGREN ASSEMBLY DISTRICT 89

Ontario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario

THE LANGUAGE OF RECOVERY

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

Self-harm in social care: 14 key points

NBPDP Drug Utilization Review Process Update

Opioid analgesic therapy in pain management: how we got here from there

Primary Care Coordination

Addiction Epidemiology, Language and Stigma

SUCCESSFUL INTERVENTIONS FOR OPIOID ADDICTION: VIEWS FROM U.S. MEDICAL PRACTITIONERS, COMMUNITY MEMBERS AND VETERANS

Legal Issues in Opioid Prescribing

The Opioid Scourge DR. CAROLINE CARNEY CHIEF MEDICAL OFFICER

Wisconsin Opioid Prescribing Guideline Draft Scope and purpose of the guideline

Medication Management

Additional file 1: Table S1. Themes developed from review of gatekeeper GP attitudes and knowledge regarding ADHD

WHAT YOU NEED TO KNOW TO ABOUT AB 474

Changing the Tide. An EMR facilitated process supporting safe and effective prescribing and de-prescribing of controlled drugs

Master s Level Certified Addiction Professional for Licensed Professionals Training Verification Form

RULES OF THE ALABAMA STATE BOARD OF MEDICAL EXAMINERS

The Opioid Addiction Emergency In Virginia June 8, 2017

Making decisions about therapy

6/6/2017. Faculty/Presenter Disclosure. Disclosure of Commercial Support

West Virginia. Prescribing and Dispensing Profile. Research current through November 2015.

Addressing the Opioid Epidemic: Prescribing Opioids for Non-Cancer Pain

European Pain Federation (EFIC) Position Paper on: Appropriate Opioid Use in Chronic Pain Management

Peer Support in Mental Health Services

Disclosure. Relationships with commercial interests:

The Changing Landscape of Opioids & Workers Compensation. Presented by: David Campbell, MA, CRC State of Michigan Workers Compensation Agency

The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015

DENOMINATOR: All patients 18 and older prescribed opiates for longer than six weeks duration

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process-High Priority

What would it take to get to zero overdose deaths in California? Kelly Pfeifer, MD May 5, 2017

CARD/MAIL/PRE-APPROVAL/PREFERRED RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date:

Test User got 22 of 22 possible points on the Risk Reduction Strategies for ER/LA Opioids Post-Test. Total score: 100 %

Approaches to Responsible Opioid Prescribing. The Opioid Naïve Patient

Cannabis for Medical Purposes

Persistent Pain in Secure Environments Health and Justice Pharmacy Network Meeting Tuesday 18 March 2014

DRUG USE AMONG ALCOHOLISM DETOXIFICATION PATIENTS PREVALENCE AND IMPACT ON ALCOHOLISM TREATMENT

I am pleased to highlight for this Honourable House and the public. that today the Government will be laying amendments to the

Data Driven Strategies

CROATIA. Venija Cerovecki, MD, GP. University of Zagreb School of Medicine Department for Family Medicine

This event is jointly sponsored by the HealthInsight New Mexico and NMPHA & NM CARES Health Disparities Center.

Guidelines for Urine Drug Monitoring for the Pain Patient in a Clinical Practice

DRUG TESTING IN PAIN MANAGEMENT AND SUBSTANCE USE DISORDER(S) TREATMENT

October 15, Division of Dockets Management (HFA 305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852

Opiate Dependency bka Opioid Addiction

Lessons Learned from the US Prescription Opioid Abuse Epidemic

HIV Knowledge and Awareness

What Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016

Integrated Treatment of Co-morbid

Understanding is the First Step

CLM 2016 Atlanta Conference May 19-20, 2016 in Atlanta, GA WHY IS PAIN MANAGEMENT SUCH AN EPIC FAIL IN WORKERS COMPENSATION CLAIMS?

Nurse Practitioner Practice Guideline Treatment Agreements

Eliminating Viral Hepatitis in Australia: Where are we in 2017?

C. Impediments to the availability of narcotic drugs

ACCESS TO PAIN MEDICATION QUESTIONNAIRE 2011, RESOLUTION 53/4

SUCCESSFUL APPROACHES TO TREATMENT FOR OPIOID ADDICTION: FOCUS ON VETERANS

Start the Conversation. Problematic Substance Use and the Workplace

Utah. Prescribing and Dispensing Profile. Research current through November 2015.

Substance Use as a Barrier to Healthy Aging: Perceptions and Experiences of Older Adults

Mental Illness and Addiction:

Prescribing drugs of dependence in general practice, Part C

Transcription:

Universal Precautions in Pain Management A Rational Approach to Management of Chronic Pain Douglas Gourlay, MD, FRCPC, FASAM Wasser Pain Management Centre; Centre for Addiction and Mental Health Toronto, Canada

Pain is an extremely common primary care complaint 80% of office visits are prompted by pain It is not well managed It is often not taken seriously by practitioner or the public Despite effective treatment options, many doctors are electing not to get involved Belief that pain doesn t kill is common

Why is this? Fear of iatrogenic problems Abuse / Addiction / Diversion Fear of regulatory sanction Concern over long-term efficacy Lack of time / Inadequate compensation

Fear of Addiction Real Pain and True Addiction are mutually exclusive NOT TRUE Prevalence of addiction in General Population is not insignificant (~10% ) Literature is biased by imprecise terminology Really have no idea what prevalence is in CNCP 10% of your patients take 90% of your time

Opioids are Addicting NOT TRUE No evidence in literature that any drug causes addiction Some drugs have higher abuse liability Only in the at-risk population, in the right setting with the right drug does addiction occur

Fear of Regulatory Sanction NOT TRUE (Regulators are Opiophobic) But in the absence of knowledge, they do some strange things Very few prescribers have been investigated by their Medical Boards due to prescription of opioids even fewer have lost license There is no expectation of physicians to act as police officers

Opioids are ineffective for CNCP NOT TRUE Literature clearly shows efficacy of opioids in CNCP but unclear for how long Not equally effective for all patients or for all types of pain, hence the term: Trial of Opioid Therapy Need a clear plan to terminate trial, if opioids are ineffective

You can identify problem patients easily, if you know what to look for NOT TRUE Very difficult diagnosis to make in pain patients even with careful limit setting No one (aberrant) behavior is pathognomonic of addiction Diagnosis of addiction is made prospectively, over time Having an addictive disorder does not rule out a treatable chronic pain problem

Universal Precautions in Infectious Disease Need to protect both the health worker (infection) AND the patient (unnecessary stigmatization) Inability to accurately identify the at-risk patient 1985 CDC published Universal Precautions A set of recommendations if applied to all patients, would reduce the risk of transmission of infectious disease

Universal Precautions in Infectious Disease The elements already existed But not collected together in one document Not universally applied By applying to all patients, three goals achieved: Reduced risk to health workers Decreased stigmatization of patients Didn t have to know who was at risk

Universal Precautions in Pain Medicine Striking similarity to infectious disease model At risk population hard to identify Incorrect assessment can lead to patient and practitioner harm All elements of the model currently exist

Universal Precautions How do we implement it? Thoroughly inquire into drug and alcohol history Set boundaries around medication use Identify aberrant behavior Triage CNCP patients managed by primary care Those managed with specialist support Tertiary level CNCP patients Assess Opioid Responsiveness through rational trials of opioid therapy

Universal Precautions in Pain Medicine 1. Diagnosis with reasonable differential 2. Psychological assessment including risk of addictive disorders 3. Informed consent 4. Treatment agreement 5. Pre and post-intervention assessment of pain level and function 6. Appropriate trial of Opioid Therapy +/- Adjuvant Meds 7. Reassessment of pain score and level of function 8. Regularly assess the 4 A s of pain medicine 9. Periodically review pain diagnosis and co-morbid conditions including addictive disorders 10. DOCUMENT, DOCUMENT, DOCUMENT

Summary By consistently applying a basic set of principles to CNCP patients Patient care is improved Stigma is reduced Overall risk is contained Universal Precautions isn t about opioid therapy: It s the basis of sound medical practice